AI Summary
Researchers have identified a new reason why CAR-T cell therapy fails in some cancer patients and are utilizing molecular scissors to improve the treatment's outcomes. This discovery is leading to new strategies involving antibodies and gene editing to enhance the effectiveness of CAR-T cell therapy for patients.
Researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in some patients. This discovery has fueled new strategies that incorporate antibodies and gene editing to improve the outcome of this breakthrough treatment for patients.